ENROLLING_BY_INVITATION

Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in Blacks

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To use practice facilitation (PF) + community health worker (CHW) facilitation as a practical and sustainable implementation strategy to support the implementation and evaluation of three multi-level evidence-based interventions \[nurse case management (NCM), remote blood pressure monitoring (RBPM), and social determinants of health (SDOH) support\] delivered as an integrated community-clinic linkage model \[Practice support And Community Engagement (PACE) to address patient-, physician-, health system-, and community-level barriers to hypertension (HTN) control in Blacks across 25 primary practices within NYU Langone Health in New York City (NYC) and, in partnership with an established Community-Clinic-Academic Advisory Board and HealthFirst (NYC's largest Medicaid payer). The goal for the UH3 Implementation Phase (Years 4-7, Intervention) is to evaluate a stepped-wedge cluster RCT of 25 primary care practices in Black patients with uncontrolled hypertension (HTN)

Official Title

Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in Blacks

Quick Facts

Study Start:2025-06-12
Study Completion:2027-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ENROLLING_BY_INVITATION

Study ID

NCT05208450

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. identifies as Black (through EHR code or self-report)
  2. 2. is 18+ years of age
  3. 3. has a diagnosis of HTN (identified by ICD-10 codes for HTN)
  4. 4. prescribed an antihypertensive medication(s)
  5. 5. has a clinic BP \> 130/80 mmHg
  1. 1. are deemed unable to comply with the study protocol (either self-selected or by indicating during screening that s/he could not complete all requested tasks)
  2. 2. participate in other hypertension-related clinical trials
  3. 3. have significant psychiatric comorbidity or reports of substance abuse (as documented in the EHR)
  4. 4. plan to discontinue care at the site within the next 12 months; or
  5. 5. are pregnant or planning to become pregnant in the next 12 months
  6. 1. NYULH Primary care provider (MD/DO, NP), Clinical Director, Site Administrator, Medical Assistant, or administrative staff employed at the participating practices and interacts with at least five patients with a diagnosis of hypertension; or
  7. 2. NYULH Nurse case manager within centralized service; or
  8. 3. Staff and leadership of community- and faith-based organizations serving the Black community; or
  9. 4. NYULH Organizational leadership; or
  10. 5. NYULH Project Staff: Community Health Workers/CHW Supervisor/Practice Facilitators; and
  11. 6. Able and willing to provide consent

Contacts and Locations

Principal Investigator

Gbenga Ogedegbe, MD, MPH
PRINCIPAL_INVESTIGATOR
NYU Langone Health
Nadia Islam, PhD
PRINCIPAL_INVESTIGATOR
NYU Langone Health
Antoinette Schoenthaler, EdD
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Gbenga Ogedegbe, MD, MPH, PRINCIPAL_INVESTIGATOR, NYU Langone Health
  • Nadia Islam, PhD, PRINCIPAL_INVESTIGATOR, NYU Langone Health
  • Antoinette Schoenthaler, EdD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-12
Study Completion Date2027-08-31

Study Record Updates

Study Start Date2025-06-12
Study Completion Date2027-08-31

Terms related to this study

Additional Relevant MeSH Terms

  • Hypertension (HTN)